Emergent BioSolutions Inc/ US29089Q1058 /
| 2024-04-26 9:59:33 PM | Chg. -0.05 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.93USD | -2.28% | 15,056 Turnover: 29,118.76 |
-Bid Size: - | -Ask Size: - | 100.23 mill.USD | - | - |
Assets
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 241.8000 | 264.2000 | 313.9790 | 331.8560 | 376.4480 | ||||||
| Intangible Assets | 0.0000 | 30.1000 | 58.3440 | 57.3750 | 33.8650 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | 513.0870 | 504.9800 | 459.8930 | ||||||
| Inventories | 15.2000 | 14.6000 | 65.6740 | 76.9360 | 74.0020 | ||||||
| Accounts Receivable | 96 | 60.6000 | 58.8340 | 120.7670 | 138.4780 | ||||||
| Cash and Cash Equivalents | 141.7000 | 179.3000 | 280.4990 | 312.7950 | 271.5130 | ||||||
| Current Assets | 263.3000 | 273.1000 | 432.1750 | 538.6120 | 510.2180 | ||||||
| Total Assets | 564.2000 | 626.6000 | 945.2620 | 1,043.5920 | 970.1110 | ||||||
Liabilities
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 31.3000 | 27.5000 | 40.9300 | 45.9660 | 34.6490 | ||||||
| Long-term debt | - | - | 251 | 253 | 248.0940 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | - | 1.4900 | - | - | - | ||||||
| Liabilities | 122.1000 | 137.5000 | 392.0610 | 383.5750 | 373.9060 | ||||||
| Share Capital | .0360 | .0370 | .0380 | .0400 | - | ||||||
| Total Equity | 442.1000 | 489.2000 | 553.2010 | 660.0170 | 596.2050 | ||||||
| Minority Interests | .8000 | -.5000 | - | - | - | ||||||
| Total liabilities equity | 564.2000 | 626.6000 | 945.2620 | 1,043.5920 | 970.1110 | ||||||
Income Statement
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 281.9000 | 312.7000 | 450.1380 | 522.7890 | 488.7820 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 30 | 42.8000 | 58.0560 | 96.0390 | 105.5220 | ||||||
| Interest Income | .1000 | .1000 | -7.9200 | -5.9510 | -6.5640 | ||||||
| Income Before Taxes | 32.1000 | 43.4000 | 53.0620 | 89.7690 | 99.2210 | ||||||
| Income Taxes | 13.9000 | 13.1000 | 16.3210 | 26.8990 | 36.6970 | ||||||
| Minority Interests Profit | 5.4000 | .9000 | - | - | - | ||||||
| Net Income | 23.5000 | 31.1000 | 36.7410 | 62.8700 | 51.7760 | ||||||
Per Share
Cash Flow
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 39.6000 | 97 | 112.3180 | 44.4590 | 53.4870 | ||||||
| Cash Flow from Investing Activities | -40.1000 | -67.9000 | -210.0520 | -45.4620 | -76.2570 | ||||||
| Cash Flow from Financing | -1.8000 | 8.6000 | 198.8740 | 33.4490 | -18.6410 | ||||||
| Decrease / Increase in Cash | -2.2000 | 37.7000 | 101.1610 | 32.2960 | -41.2820 | ||||||
| Employees | 877 | 1,353 | 1,280 | 1,292 | 1,098 | ||||||
